A validated UPLC–MS/MS method for flibanserin in plasma and its pharmacokinetic interaction with bosentan in rats

Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study

(2017) David J. Portman et al.   Journal of Sexual Medicine

Flibanserin for hypoactive sexual desire disorder: place in therapy

(2017) Faina Gelman et al.   Therapeutic Advances in Chronic Disease

FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire Disorder

(2016) Hylton V. Joffe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Flibanserin: First Global Approval

(2015) Emma D. Deeks   DRUGS

The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus

(2015) A. Cayir et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension

(2011) Jürgen Venitz et al.   JOURNAL OF CLINICAL PHARMACOLOGY